Brief: USANA Health Sciences Revises 2022 Net Sales And Diluted EPS Outlook

USANA Health Sciences

25/10/2022 23:01

Oct 25 (Reuters) - Usana Health Sciences Inc  USNA.N :
    * USANA HEALTH SCIENCES REPORTS THIRD QUARTER RESULTS
    * Q3 SALES $233.0 MILLION VERSUS $274.0 MILLION
    * Q3 EARNINGS PER SHARE $0.78
    * REVISES FISCAL 2022 NET SALES AND DILUTED EPS OUTLOOK TO
$955
MILLION TO $975 MILLION AND $3.15 TO $3.40, RESPECTIVELY
    * Q3 EARNINGS PER SHARE VIEW $0.89, REVENUE VIEW $244.2
MILLION --
REFINITIV IBES DATA
    * FY2022 EARNINGS PER SHARE VIEW $3.90, REVENUE VIEW $1.03
BILLION
-- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw71zKzWa 
Further company coverage:  USNA.N 
 ((Reuters.Briefs@thomsonreuters.com;))